Athersys Inc (ATHXQ)

[goupupup]

HELLLOOOOOOOOOO DOC SHORTY .. Short covering !!!!!!!!!!!!!!!

https://shortsqueeze.com/?symbol=athx

Alterity Therapeutics Launcheed ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy in Europe
7:38 am ET August 25, 2022 (Benzinga) Print
Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced the Company's Phase 2 clinical trial of ATH434 for the treatment of patients with Multiple System Atrophy (MSA) is now open for enrolment in the United Kingdom.